<i>In Vivo</i> investigation of xenotransplanted human blood-derived scaffold into mice as a biodegradable construct for improvement of pelvic floor repair
Behnia-Willison F., Aryan P., Salehnia M., Willison N., Nguyen TTT., Tansu N.
Animal Study on Scar, published in Front Bioeng Biotechnol (2025) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Animal Study
- Journal
- Front Bioeng Biotechnol (2025)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 41079052
- PMCID
- PMC12511874
- DOI
- 10.3389/fbioe.2025.1627538
Abstract (original English)
Objective We developed an autologous, novel human blood-derived scaffold (hBDS) to improve pelvic floor disorders. Both in vivo biocompatibility and biodegradation were investigated and compared by subcutaneous implantation, in the abdominal wall, and the back muscle of mice. Methods and materials After preparing the scaffold, it was xenotransplanted subcutaneously, and in vivo biodegradation and host responses were assessed morphologically using hematoxylin, eosin, and Masson's trichrome staining over 6 weeks. Immunohistochemistry for the CD136 marker was conducted to evaluate vascularization. In another series of experiments, the scaffold was sutured at multiple points on the abdominal wall and back muscle to prolong its biodegradation time and assess the scar formation around the transplantation site. Results Three days after implantation, no infection or severe inflammation was observed, and the scaffold was surrounded by connective tissue and fibroblasts, indicating initial scaffold degradation. By 1 week, the scaffold exhibited high biodegradation and increased fibroblast infiltration. Scaffold degradation was extensive at 2 weeks, with continued fibroblast infiltration and new collagen deposition. By 3 weeks, the scaffold had completely degraded, with minimal inflammation. The normal dermal structure was restored by weeks four to six after transplantation. Immunohistoche
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewPubMed
Clinical Applications of Autologous Fat Grafting in Pathological Hand Conditions.
Systematic Review with a reported sample of 7 on Osteoarthritis, Scar, published in J Hand Surg Asian Pac Vol (2026) — summary generated from the PubMed abstract.
- 2026
- n = 7
J Hand Surg Asian Pac Vol - Level AMeta-analysisPubMed
Stem cell therapy in thin endometrium and Asherman's syndrome: a systematic review and meta-analysis.
Meta-analysis with a reported sample of 323 on Scar, published in Eur J Obstet Gynecol Reprod Biol (2026) — summary generated from the PubMed abstract.
- 2026
- n = 323
Eur J Obstet Gynecol Reprod Biol - Level AMeta-analysisEurope PMC
Therapeutic value of mesenchymal stem cell-derived extracellular vesicles in hypertrophic and keloid scars: a systematic review and meta-analysis
Meta-analysis on Chronic Wound, Scar, published in Front Cell Dev Biol (2026) — summary generated from the PubMed abstract.
- 2026
Front Cell Dev Biol - Level AMeta-analysisPubMed
Efficacy and safety of autologous cell-based therapies for atrophic acne scar treatment: an updated systematic review and meta-analysis with in-depth methodological and clinical insights.
Meta-analysis with a reported sample of 500 on Chronic Wound, Scar, published in Front Cell Dev Biol (2026) — summary generated from the PubMed abstract.
- 2026
- n = 500
Front Cell Dev Biol - Level ASystematic ReviewEurope PMC
Comparative Efficacy and Safety of Fractional CO<sub>2</sub> Laser and Gold Microneedling Radiofrequency for Atrophic Acne Scars: A Systematic Review
Systematic Review on Chronic Wound, Scar, published in Skin Res Technol (2026) — summary generated from the PubMed abstract.
- 2026
Skin Res Technol - Level AMeta-analysisPubMed
Role of exosome therapy in reconstructive surgery: a review.
Meta-analysis on Chronic Wound, Scar, Immune Modulation, published in Front Med (Lausanne) (2026) — summary generated from the PubMed abstract.
- 2026
Front Med (Lausanne)1 citations